Audited Results of Bal Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	310.80	302.50	338.54	303.10	280.37
Manufacturing Expenses	9.47	8.29	7.57	6.71	5.37
Personnel Expenses	65.92	61.83	56.11	51.91	44.46
Selling Expenses	4.46	4.65	3.21	2.90	2.22
Administrative Expenses	40.21	39.50	47.15	45.16	38.35
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	278.57	272.42	306.10	277.07	257.16
Operating Profit	32.23	30.08	32.44	26.03	23.20
Other Recurring Income	2	2.15	3.35	2.15	6.49
Adjusted PBDIT	34.23	32.23	35.79	28.19	29.69
Financial Expenses	16.81	16.85	15.24	12.16	10.40
Depreciation	11.06	9.65	8.45	7.48	7.24
Other Write offs	0	0	0	0	0
Adjusted PBT	6.37	5.73	12.11	8.55	12.06
Tax Charges	-0.39	-2.07	1.83	2.42	3.48
Adjusted PAT	6.75	7.80	10.27	6.13	8.58
Non Recurring Items	0	-0.05	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	6.75	7.80	10.27	6.13	8.58
Equity Dividend	1.91	1.91	1.57	1.56	1.48
Preference Dividend	0	0	0	0	0
Retained Earnings	53.58	48.74	55.64	46.94	42.37

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article